128 Pharmaceutical startups in the UK (free list)
Track funded UK pharmaceutical companies, founders and investors across the UK startup ecosystem.
Updated daily by John-Pierre ClarkUpdated daily by John-Pierre Clark| Date | Startup | Funding | Round | Sector | Location | Connect | Website | Investor1 | Investor2 | Investor3 | Investor4 | Investor5 | Founder(s) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6 Nov 2026 |  bio.bit bio.bit supplies human cell models and an opti-ox platform that programs ce... | £18,570,000 US$25,000,000 | |||||||||||
5 Nov 2026 |  FluoRok A manufacturing platform that produces fluorochemicals without hydrogen flu... | £22,270,000 US$30,000,000 | |||||||||||
5 Nov 2026 |  T-Therapeutics T-Therapeutics develops therapies that use a platform to supply fully human... | £100,000,000 | |||||||||||
5 Nov 2026 |  Potential Sciences Potential Sciences offers a software platform that generates large-scale qu... | ||||||||||||
3 Nov 2026 |  1nhaler 1nhaler Salbutamol is a single-use, mostly cardboard inhaler that folds fro... | £2,000,000 | |||||||||||
26 Oct 2026 |  imphatec A small implant placed under the skin that steadily releases medication ove... | £1,500,000 | |||||||||||
16 Oct 2026 |  Microbiotica MB310 is an oral once-daily live biotherapeutic capsule containing eight sp... | £36,000,000 | |||||||||||
16 Oct 2026 |  Medcotec The Helyx valve is a single-use, full-bore powder transfer valve for pharma... | £2,400,000 | Daresbury  | ||||||||||
16 Oct 2026 |  OMass Therapeutics OMS1620 is a small-molecule drug that binds the MC2 receptor to modify rece... | £233,750,000 US$310,000,000 | |||||||||||
14 Oct 2026 |  HydRegen HydRegen provides a bio-based hydrogenation platform that formulates enzyme... | £6,040,000 US$8,000,000 | |||||||||||
13 Oct 2026 |  Undecimal Bio DELiveri is a platform that uses chemical screening and machine learning to... | £14,000,000 | |||||||||||
8 Oct 2026 |  Universal Quantum Universal Quantum makes modular trapped-ion computing systems assembled fro... | £75,670,000 US$100,000,000 | Haywards Heath | ||||||||||
7 Oct 2026 |  Cori Clinical Cori Clinical provides an AI workspace that assembles internal trial knowle... | £3,020,000 US$4,000,000 | |||||||||||
6 Oct 2026 |  Sensible Biotechnologies A cell-based platform that produces naturally modified mRNA using engineere... | £35,550,000 US$47,000,000 | |||||||||||
24 Sept 2026 |  Basecamp Research Basecamp Research offers a drug discovery platform that combines genetic da... | £105,630,000 US$140,000,000 | |||||||||||
23 Sept 2026 |  StandardX StandardX offers an accelerator-based isotope refinery that produces a rang... | £10,000,000 | |||||||||||
22 Sept 2026 |  SageTech Medical SageTech Medical supplies a recycling system for waste anaesthetic in hospi... | £2,500,000 | Devon | ||||||||||
18 Sept 2026 |  Big Picture Bio Big Picture Bio provides a platform that uses AI to model disease and propo... | £1,500,000 | |||||||||||
17 Sept 2026 |  Chemify Chemify provides an automated chemistry discovery platform combining labora... | £22,000,000 | |||||||||||
17 Sept 2026 |  MicroLub A protein-based ingredient that replaces fat's lubricating role with water ... | £7,500,000 | Leeds | ||||||||||
15 Sept 2026 |  Magnitude Biosciences VivoScan is a platform that tests chemical compounds in living C. elegans u... | £1,300,000 | Durham | ||||||||||
15 Sept 2026 |  Fuse Diagnostics Flip is an instrument-free molecular diagnostics platform combining proprie... | £1,000,000 | |||||||||||
9 Sept 2026 |  ViaNautis polyNaut® is a non-viral delivery platform that uses targeted polymer nanov... | €20,000,000 | |||||||||||
4 Sept 2026 |  Siguru Siguru offers an AI platform that automates medical, legal and regulatory r... | ||||||||||||
2 Sept 2026 |  Pharosyn Pharosyn provides AI infrastructure and data integrations that embed into p... | £2,220,000 US$3,000,000 | |||||||||||
1 Sept 2026 |  Healome Therapeutics Healome Therapeutics develops biomaterial scaffolds for clinical tissue rep... | ||||||||||||
23 Jul 2026 |  Moa Technology Moa Technology offers a discovery platform and product pipeline for herbici... | £22,200,000 | |||||||||||
14 Jul 2026 |  Draig Therapeutics DT-101 is an AMPA receptor potentiator and positive allosteric modulator. I... | £48,640,000 US$65,000,000 | Cardiff | ||||||||||
10 Jul 2026 |  Alchemab Therapeutics Resiliome is a platform that combines deep sequencing of antibodies with a ... | £25,000,000 | |||||||||||
6 Jul 2026 |  Revolver Therapeutics Revolver Therapeutics provides a discovery platform and peptide therapeutic... | £572 | Bath |
1 Explore 128 UK pharmaceutical startups and their founders, who have collectively raised £4.95B.
2 Easily sort, filter, and compare the UK's top startups — customise the list to your needs.
3 Discover top startups for investment, B2B sales, partnerships, hiring, and industry connections.
You can connect with fast-growing pharmaceutical startups with the full list of recently funded startups from the UK.
With UK-based startups such as Ignota Labs, Medherant, and Stablepharma, the UK's pharmaceutical sector has rapidly become a hub for innovative drug development and delivery solutions. Driven by advancements in biotechnology, artificial intelligence, and a commitment to addressing unmet medical needs, pharmaceutical startups are transforming the landscape of healthcare by introducing novel therapies and improving patient outcomes.
What does it mean to be a pharmaceutical startup?
Pharmaceutical startups are companies that focus on the research, development, and commercialisation of new drugs and therapies. They aim to address various medical conditions by discovering novel compounds, repurposing existing drugs, or enhancing drug delivery methods to improve efficacy and patient compliance.
These startups operate across diverse therapeutic areas, including oncology, neurology, and infectious diseases, often leveraging cutting-edge technologies such as artificial intelligence for drug discovery and development. By integrating scientific research with innovative approaches, they contribute to the advancement of medical science and the availability of new treatments.
With substantial funding and support from both the public and pharmaceutical investors, this ecosystem continues to expand rapidly. Let’s explore the key areas currently driving innovation within pharmaceutical startups:
Type 5 types of pharmaceutical startups
Pharmaceutical startups in the UK are pioneering advancements across various domains by harnessing technological innovations and scientific research. Here are five distinct categories of pharmaceutical startups:
AI-Driven Drug Discovery
Companies utilising artificial intelligence to streamline the drug discovery process, reducing time and costs associated with bringing new medications to market (examples: Ignota Labs, BenevolentAI).
Transdermal Drug Delivery
Startups developing advanced transdermal patches for drug delivery, offering controlled release and improved patient compliance (examples: Medherant).
Vaccine Stabilisation Technologies
Companies working on stabilising vaccines to eliminate the need for cold chain storage, enhancing accessibility in various regions (examples: Stablepharma).
Psychedelic Medicine Development
Startups researching and developing psychedelic compounds for therapeutic use in mental health and neurological disorders (examples: Eleusis).
Digital Pharmaceutical Platforms
Companies creating digital tools to support pharmaceutical access, adherence, and patient engagement (examples: Healthera, Charac).